K
Kwang Hyub Han
Researcher at Yonsei University
Publications - 694
Citations - 36674
Kwang Hyub Han is an academic researcher from Yonsei University. The author has contributed to research in topics: Hepatocellular carcinoma & Hepatitis B virus. The author has an hindex of 80, co-authored 692 publications receiving 30974 citations. Previous affiliations of Kwang Hyub Han include University Health System.
Papers
More filters
Journal ArticleDOI
Impact of controlled attenuation parameter on detecting fibrosis using liver stiffness measurement
Thomas Karlas,David Petroff,Magali Sasso,Jian-Gao Fan,Y. Q. Mi,V. de Ledinghen,Maneesh Kumar,Monica Lupsor-Platon,Kwang Hyub Han,A.C. Cardoso,Giovanna Ferraioli,Wah-Kheong Chan,Vincent Wai-Sun Wong,R. Myers,Kazuaki Chayama,Mireen Friedrich-Rust,Michel Beaugrand,Feng Shen,Jean-Baptiste Hiriart,Shiv Kumar Sarin,Radu Badea,H. W. Lee,Patrick Marcellin,Carlo Filice,Sanjiv Mahadeva,Grace Lai-Hung Wong,Pam Crotty,Keiichi Masaki,Jörg Bojunga,P. Bedossa,Volker Keim,Johannes Wiegand +31 more
TL;DR: Control Attenuation Parameter (CAP) added to transient elastography enables simultaneous assessment of steatosis and fibrosis in patients with non‐alcoholic fatty liver disease.
Discordance between liver biopsy and Fibroscan® in assessing liver fibrosis in chronic hepatitis b: risk factors and influence of necroinflammation
TL;DR: Advanced fibrosis stage (F3–4) or cirrhosis (F4) showed a negative correlation with discordance between LB and LSM in patients with CHB, and maximal activity grade 3–4 significantly influenced LSM values in F3 and F4.
Journal ArticleDOI
Outcomes of Long-term Treatment of Chronic HBV Infection With Entecavir or Other Agents From a Randomized Trial in 24 Countries
Jin Lin Hou,Wei Zhao,Changhyeong Lee,Hie-Won Hann,Cheng Yuan Peng,Tawesak Tanwandee,Viacheslav Morozov,Hartwig Klinker,Jose D. Sollano,Adrian Streinu-Cercel,Hugo Cheinquer,Qing Xie,Yu Ming Wang,Lai Wei,Ji Dong Jia,Guozhong Gong,Kwang Hyub Han,Wukui Cao,Mingliang Cheng,Xiaoping Tang,Deming Tan,Hong Ren,Zhongping Duan,Hong Tang,Zhiliang Gao,Shijun Chen,Shumei Lin,Jifang Sheng,Chengwei Chen,Jia Shang,Tao Han,Yanyan Ji,Junqi Niu,Jian Sun,Yongpeng Chen,E. Cooney,Seng Gee Lim +36 more
TL;DR: In a randomized controlled trial of patients with chronic HBV infection, entecavir therapy is associated with a low rate of adverse events over 10 years of follow up and participants in a China cohort who maintained a virologic response had a reduced risk of HBV-related outcome events including hepatocellular carcinoma.
Journal ArticleDOI
How to predict HCC development in patients with chronic B viral liver disease
Kwang Hyub Han,Sang Hoon Ahn +1 more
TL;DR: The usefulness of a tailored screening program with IPM for HCC was prospectively confirmed and the effective screening system for diagnosis of HCC limited to patients with chronic hepatitis B might be necessitated in high endemic area.
Journal ArticleDOI
Prospective validation of FibroTest in comparison with liver stiffness for predicting liver fibrosis in Asian subjects with chronic hepatitis B
Beom Kyung Kim,Seung Up Kim,Hyon Suk Kim,Jun Yong Park,Sang Hoon Ahn,Chae Yoon Chon,In Rae Cho,Dong Hoo Joh,Young Nyun Park,Kwang Hyub Han,Do Young Kim +10 more
TL;DR: Wang et al. as mentioned in this paper evaluated the performance of FibroTest (FT) for hepatic fibrosis in Asian chronic hepatitis B (CHB) patients and found that FT substantially reduces the need for liver biopsy.